EVER vs EW · P/E 6.6, rev $500.2M vs P/E 47, rev $1.39B
EverQuote Inc Class A (EVER) versus Edwards Lifesciences Corp (EW) — a side-by-side from cached financials, not a winner call.
EverQuote Inc Class A (EVER) is a internet content & information company listed on US.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Latest reported EVER revenue for 2024-12-31 was $500.2M. Net income was $32.2M. Revenue was up 73.7% from 2023-12-31 to 2024-12-31. EVER currently screens at market cap $683.4M and trailing P/E 6.6.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
EVER currently screens at market cap $683.4M and trailing P/E 6.6. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Not investment advice. Open the EVER and EW stock pages for the full models.
Not investment advice.